San
Francisco, 03 December 2018, The global structural heart devices market is expected to reach USD
9.1 billion by 2025, based on a new report by Grand View Research, Inc. The
market is expected to witness an exponential growth over the next 8 years due
to the rapid increase in cardiovascular conditions and increasing power of
healthcare expenditure.
The defects are mostly present
at birth, thereby directly affecting the under-5 mortality rate of a country.
Therefore, rigorous actions are being undertaken by various government bodies
across the globe to increase access to treatment. The Centers for Disease
Control and Prevention have a public action plan to efficient management of
cardiac conditions.
In addition, other organizations are working on improving
the scenario for structural heart diseases treatment. For instance, in November
2016, the Cardiovascular Research Foundation (CRF) announced a launch of a
journal focusing on diagnosis and treatment of structural heart defects. It was
titled Structural Heart: The Journal of the Heart Teamand is
expected to be launched in May 2017. This is expected to trigger research &
development activities along with capital invested in this field, resulting in
technological advancements.
Access Full Research
Report On Structural Heart Devices Market Analysis:
www.grandviewresearch.com/industry-analysis/structural-heart-devices-market
www.grandviewresearch.com/industry-analysis/structural-heart-devices-market
Further key findings from the study suggest:
·
Surgical Aortic Valve
Replacement (SAVR) dominated the market in 2016, closely followed by
Transcatheter Aortic Valve Replacement (TAVR). It can be attributed to the
longest presence of the technique in the treatment regimen of aortic stenosis
·
Left Atrial Appendage Closure
(LAAC) is anticipated to be one of the fastest growing segment owing to the
minimally invasive nature of the procedure. It also helps in reduction of risk
of stroke, thus is projected to have a higher demand
·
Geographically, North America
held the largest market share in 2016 and is expected to maintain its position
during the forecast period. High prevalence of cognitive heart diseases is the
key reason for this dominance. Moreover, the mandatory CCHD screening for
newborns imposed by the Centers for Disease Control and Prevention (CDC) and
American Academy of Pediatrics (AAP) in September 2014 also contributes to the
growth in this region
·
Asia Pacific is also expected
to witness a rapid growth over the forecast period. The improved access and
capability for treatments in this region is the key reason for this growth
·
Some of the key players are
Medtronic, ST. JUDE MEDICAL, Boston Scientific Corporation, CardioKinetix,
Comed BV, Edwards Lifesciences Corporation, LivaNova PLC, Abbott Laboratories,
JenaValve Technology, Inc., and Biomerics
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/healthcare
Grand View Research has segmented the
structural heart devices market by type and region:
Type Outlook (Market Revenue in
USD Million, 2014 - 2025)
·
SAVR
·
TAVR
·
Mitral Repair (Annuloplasty)
·
LAAC
Regional Outlook (Market
Revenue in USD Million, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
UK
o
Germany
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
Middle East and Africa
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-structural-heart-devices-market
www.grandviewresearch.com/press-release/global-structural-heart-devices-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
